Emcure Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|
| Revenue | 1,283.36 | 1,118.10 | 1,300.58 |
| Operating Expense | 1,036.01 | 872.07 | 1,033.55 |
| Net Profit | 117.62 | 122.79 | 139.56 |
| Net Profit Margin | 9.17 | 10.98 | 10.73 |
| Earning Per Share | 6.21 | 6.48 | 7.37 |
| EBIDTA | 253.05 | 247.15 | 284.13 |
| Effective Tax Rate | 18.59 | 17.88 | 23.81 |
| Particulars | Sep 2025 |
|---|---|
| Revenue | 1283.36 |
| Operating Expense | 1036.01 |
| Net Profit | 117.62 |
| Net Profit Margin | 9.17 |
| Earning Per Share | 6.21 |
| EBIDTA | 253.05 |
| Effective Tax Rate | 18.59 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 4,381.92 | 3,497.66 | 3,107.09 |
| Operating Expenses Annual | 3,758.76 | 3,055.76 | 2,668.59 |
| Operating Profit Annual | 765.64 | 570.84 | 557.70 |
| Interest Annual | 112.96 | 166.09 | 166.83 |
| Depreciation | 208.71 | 189.26 | 156.51 |
| Net Profit Annual | 317.13 | 160.83 | 160.06 |
| Tax Annual | 110.58 | 39.08 | 52.28 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 4,381.92 |
| Operating Expenses Annual | 3,758.76 |
| Operating Profit Annual | 765.64 |
| Interest Annual | 112.96 |
| Depreciation | 208.71 |
| Net Profit Annual | 317.13 |
| Tax Annual | 110.58 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | -88.91 | -213.05 | -393.35 |
| Cash Flow from Operations | 558.29 | 584.97 | 505.37 |
| Cash Flow from Investing | -437.66 | -173.08 | -270.56 |
| Cash Flow from Financing | -49.25 | -287.75 | -54.52 |
| Cash Flow at the End | -17.53 | -88.91 | -213.05 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | -88.91 |
| Cash Flow from Operations | 558.29 |
| Cash Flow from Investing | -437.66 |
| Cash Flow from Financing | -49.25 |
| Cash Flow at the End | -17.53 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 17.47 | 16.32 | 17.95 |
| PBIT Margin (%) | 12.34 | 10.46 | 12.20 |
| PBT Margin (%) | 12.23 | 10.40 | 12.13 |
| Net PROFIT Margin (%) | 7.24 | 4.60 | 5.15 |
| Return On Networth / Equity (%) | 12.79 | 8.52 | 9.01 |
| Return On Networth /Employed (%) | 14.36 | 10.08 | 10.69 |
| Return On Assets (%) | 8.40 | 4.41 | 4.53 |
| Total Debt / Equity (X) | 0.49 | 0.89 | 0.94 |
| Asset Turnover Ratio (%) | 1.16 | 0.96 | 0.88 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 17.47 |
| PBIT Margin (%) | 12.34 |
| PBT Margin (%) | 12.23 |
| Net PROFIT Margin (%) | 7.24 |
| Return On Networth / Equity (%) | 12.79 |
| Return On Networth /Employed (%) | 14.36 |
| Return On Assets (%) | 8.40 |
| Total Debt / Equity (X) | 0.49 |
| Asset Turnover Ratio (%) | 1.16 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 1,765.34 | 1,718.24 | 1,432.71 |
| Total Current Assets Annual | 2,460.05 | 2,123.43 | 2,139.51 |
| Non Current Assets Annual | 2,956.06 | 2,633.50 | 2,476.34 |
| Total Shareholders Funds Annual | 3,024.36 | 1,935.10 | 1,841.87 |
| Total Assets Annual | 5,416.11 | 4,756.93 | 4,615.85 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 1,765.34 |
| Total Current Assets Annual | 2,460.05 |
| Non Current Assets Annual | 2,956.06 |
| Total Shareholders Funds Annual | 3,024.36 |
| Total Assets Annual | 5,416.11 |
EPS (INR)
Expected
12.84
Reported
12.85
Surprise
0.08%
Jun 2025
EPS beaten by 0.08%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.00%
